Company Overview

Development Stage

About the Company

[Summary] 为全球肿瘤患者带来更好的治疗方案

宜联生物成立于2020年,是一家专注于开发创新型偶联药物的临床阶段生物科技公司。公司开发的新一代具有自主知识产权的肿瘤微环境可激活的新型毒素连接子平台技术(TMALIN®)可实现高DAR值高均一性的稳定偶联,有助于提高ADC药物在实体瘤适应症上的治疗窗。公司致力于以未满足的临床需求为目标,为全球肿瘤患者带来更好的治疗方案。宜联生物位于中国苏州,并在中国上海、美国波士顿建立研发分支机构。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

宜联生物 How Fast Is Hiring Growing? (172 open positions)

Manage
Note: How fast is hiring at 苏州宜联生物医药有限公司 growing? 宜联生物2026: 225 openings (up 281%), 2025: 59 openings (up 34%), 2024: 44 openings (down 4%), 2023: 46 openings (down 16%), 2022: 55 openings (up 90%), 2021: 29 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

宜联生物 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 27%
  • 2024: Up 7%
  • 2023: Up 27%
  • 2022: Up 38%
宜联生物 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 苏州宜联生物医药有限公司 growing? 宜联生物Master's recruitment over the years: 2025: 19 openings (up 27%), 2024: 15 openings (up 7%), 2023: 14 openings (up 27%), 2022: 11 openings (up 38%), 2021: 8 openings.

宜联生物 Doctoral Degree Job Demand Analysis

(More)
+1325%
Growth Rate
2026 vs 2025
  • 2025: Down 20%
  • 2024: Down 69%
  • 2023: Up 129%
宜联生物 Doctoral Hiring by Year: 2026 — 53 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 苏州宜联生物医药有限公司 growing? 宜联生物Doctorate recruitment over the years: 2026: 57 openings (up 1325%), 2025: 4 openings (down 20%), 2024: 5 openings (down 69%), 2023: 16 openings (up 129%), 2022: 7 openings.

宜联生物 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 苏州宜联生物医药有限公司? Based on an analysis of 宜联生物's job postings over the past year, "生物/制药/化工/环保类" demand: 58.3%, "科研类": 28.2%, "其他(研发和技术类)": 23.1%, "医疗卫生/美容保健类": 9%, "计算机/网络/技术类": 5.1%, "美术/设计/创意类": 2.6%. For reference only.

宜联生物 — What Are the Salaries Like? (156 records)

Manage
salary range: 3K - 50K, 72.4% of roles pay ¥15-50K
Note: salary statistics are based on 156 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 苏州宜联生物医药有限公司?宜联生物72.4% of positions earn 15-50K, Fresh graduate salary: ¥14.4K。Suzhou salary ranking top 30,生物/制药/化工/环保类 average salary ¥25.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 宜联生物

(More)
Are salaries high at 苏州宜联生物医药有限公司? We provide: 研究员,科学家,分析,qc,ra,副总,高级经理,临床,细胞培养,bp,hr,运维,实习生,技术支持,pm,产品经理,供应链,信息,制剂研究,有机合成. Click to view detailed salary analysis by job.

宜联生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

宜联生物 Related Industry Tags

Job Category

  • 生物/制药/化工/环保类
    56.6% of total 56.6%
  • 科研类
    26.2% of total 26.2%
  • 其他(研发和技术类)
    19.5% of total 19.5%
  • 经营管理类
    19.1% of total 19.1%

Education

  • 本科
    31.1% of total 31.1%
  • 不限
    24.7% of total 24.7%
  • 硕士
    21.7% of total 21.7%
  • 博士
    21.7% of total 21.7%

Experience

  • 不限
    55.1% of total 55.1%
  • 5-10年
    17.2% of total 17.2%
  • 3-5年
    15% of total 15%
  • 1-3年
    7.1% of total 7.1%
View Detailed Analysis

What does 苏州宜联生物医药有限公司 require? Who is 宜联生物 hiring? 宜联生物 recruitment: 生物/制药/化工/环保类占比最多占56.6%,其次是科研类占26.2%. What education can get in at 宜联生物? 本科占比最多占31.1%,其次是不限占24.7%. High education required at 宜联生物? 硕士占21.7%,博士占21.7%. Work experience required at 宜联生物? 不限占比最多占55.1%,其次是5-10年占17.2%. Where are the job locations at 宜联生物? 苏州占比最多占80.9%,其次是上海占12%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 67,602.1815万(元)
Legal Representative: 薛彤彤
Date Established:
Credit Code: 91320594MA21XFX7XK
Registered Address: 中国(江苏)自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园B3楼101单元

Partners & Suppliers

宜联生物与BioNTech就一款ADC药物达成全球独家许可协议,BioNTech获得该药物的开发和商业化权利 Source
合作客户 制药合作
宜联生物利用和铂医药的HCAb技术平台开发ADC药物 Source
供应商 制药合作

People who follow 宜联生物 also follow

宜联生物 Competitors (Similar Companies)

“To develop high-quality biologics that are accessible and affordable f”
“Committed to the independent R&D, production, and sales of innovative ”
“Continuous innovation, safeguarding health”
生命科学 生物信息 生物制药 干细胞
“Providing solutions for personalized treatment and health management”
医药 生物医药 创新药 制药/药业
“Specializing in R&D, production, and sales of high-precision, high-per”
“专注于抗肿瘤药品研发与国际营销的公司”
制药/药业 生物制药 医药中间体 原料药
“Continuously innovating to bring patients medicines that significantly”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Research, development, and production of anti-tumor and surgical medic”
“A biotechnology company focused on genomic research and gene technolog”
中间体 生产 原料药 中间体生产
制药/药业 抗体 蛋白质工程 生物制药

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates